This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Adolescent Medicine  • Pediatrics, Other  • Substance Abuse/ Alcoholism  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Pediatr Adolesc Med. 2006;160:854.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We agree with Drs Warner and Friedmann that the detection of illicit substances such as oxycodone and ecstasy (3,4 methylenedioxymethamphetamine) by immunoassay screens depends on the particular screen used, and indeed, some commercial products are able to detect these compounds in urine. Our study was conducted in 2004 when the preferred assays used in standard drug-testing laboratories did not reliably detect ecstasy, as noted in the footnote to Table 2, and to date, the majority of opioid screens do not include oxycodone. However, even if we discount these items from our questionnaire analysis, our conclusion that the primary care workforce is not currently prepared to support widespread implementation of urine drug testing would not change. Moreover, the variability in what is included in a "standard panel" among available urine screening products underscores the complexity of this procedure. Furthermore, prior research by our team examined Internet-based information regarding home . . . [Full Text of this Article]

AUTHOR INFORMATION

Sharon Levy, MD, MPH; Sion Kim Harris, PhD; Lon Sherritt, MPH; Michelle Angulo, BA; John R. Knight, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Laboratory Testing for Drug Abuse
Elizabeth A. Warner and Peter D. Friedmann
Arch Pediatr Adolesc Med. 2006;160(8):854.
EXTRACT | FULL TEXT